You signed in with another tab or window. Reload to refresh your session.You signed out in another tab or window. Reload to refresh your session.You switched accounts on another tab or window. Reload to refresh your session.Dismiss alert
The cancer exome ring trial requires the pipeline to compute a score for homologous recombination deficiency.
The R package scarHRD provides such a score, and it is the software recommended for that purpose by the ring trial organisers.
We are not aware of alternatives to scarHRD, certainly not computing the individual scores (loss of heterozygosity, telomeric allelic imbalances and large scale transitions) together.
However, there are significant drawbacks to scarHRD:
The software is only available through github, it is neither in CRAN nor in Bioconductor nor in Bioconda.
The cancer exome ring trial requires the pipeline to compute a score for homologous recombination deficiency.
The R package scarHRD provides such a score, and it is the software recommended for that purpose by the ring trial organisers.
We are not aware of alternatives to
scarHRD
, certainly not computing the individual scores (loss of heterozygosity, telomeric allelic imbalances and large scale transitions) together.However, there are significant drawbacks to
scarHRD
:The text was updated successfully, but these errors were encountered: